• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合抗菌治疗与宿主免疫以对抗耐药性感染:传统治疗与适应性治疗

Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment.

作者信息

Gjini Erida, Brito Patricia H

机构信息

Instituto Gulbenkian de Ciência, Oeiras, Portugal.

Nova Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.

出版信息

PLoS Comput Biol. 2016 Apr 14;12(4):e1004857. doi: 10.1371/journal.pcbi.1004857. eCollection 2016 Apr.

DOI:10.1371/journal.pcbi.1004857
PMID:27078624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4831758/
Abstract

Antimicrobial resistance of infectious agents is a growing problem worldwide. To prevent the continuing selection and spread of drug resistance, rational design of antibiotic treatment is needed, and the question of aggressive vs. moderate therapies is currently heatedly debated. Host immunity is an important, but often-overlooked factor in the clearance of drug-resistant infections. In this work, we compare aggressive and moderate antibiotic treatment, accounting for host immunity effects. We use mathematical modelling of within-host infection dynamics to study the interplay between pathogen-dependent host immune responses and antibiotic treatment. We compare classical (fixed dose and duration) and adaptive (coupled to pathogen load) treatment regimes, exploring systematically infection outcomes such as time to clearance, immunopathology, host immunization, and selection of resistant bacteria. Our analysis and simulations uncover effective treatment strategies that promote synergy between the host immune system and the antimicrobial drug in clearing infection. Both in classical and adaptive treatment, we quantify how treatment timing and the strength of the immune response determine the success of moderate therapies. We explain key parameters and dimensions, where an adaptive regime differs from classical treatment, bringing new insight into the ongoing debate of resistance management. Emphasizing the sensitivity of treatment outcomes to the balance between external antibiotic intervention and endogenous natural defenses, our study calls for more empirical attention to host immunity processes.

摘要

感染病原体的抗菌耐药性在全球范围内是一个日益严重的问题。为防止耐药性的持续选择和传播,需要合理设计抗生素治疗方案,目前关于积极治疗与适度治疗的问题正在激烈辩论。宿主免疫是清除耐药感染的一个重要但常被忽视的因素。在这项工作中,我们比较了积极和适度的抗生素治疗,并考虑了宿主免疫效应。我们使用宿主内感染动态的数学模型来研究病原体依赖的宿主免疫反应与抗生素治疗之间的相互作用。我们比较了经典(固定剂量和持续时间)和适应性(与病原体载量耦合)治疗方案,系统地探索了感染结果,如清除时间、免疫病理学、宿主免疫以及耐药细菌的选择。我们的分析和模拟揭示了在清除感染过程中促进宿主免疫系统与抗菌药物协同作用的有效治疗策略。在经典治疗和适应性治疗中,我们都量化了治疗时机和免疫反应强度如何决定适度治疗的成功。我们解释了适应性方案与经典治疗不同的关键参数和维度,为正在进行的耐药性管理辩论带来了新的见解。我们的研究强调了治疗结果对外部抗生素干预和内源性自然防御之间平衡的敏感性,呼吁更多地从实证角度关注宿主免疫过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/3321c48c116f/pcbi.1004857.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/72001a85eb2a/pcbi.1004857.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/4e8f6c7fc688/pcbi.1004857.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/f3b3536d3cd1/pcbi.1004857.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/35827e65491b/pcbi.1004857.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/f672461fe1fe/pcbi.1004857.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/499c43d1cbc4/pcbi.1004857.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/5aaede9d7ba7/pcbi.1004857.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/01ef389c5ca2/pcbi.1004857.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/3321c48c116f/pcbi.1004857.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/72001a85eb2a/pcbi.1004857.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/4e8f6c7fc688/pcbi.1004857.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/f3b3536d3cd1/pcbi.1004857.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/35827e65491b/pcbi.1004857.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/f672461fe1fe/pcbi.1004857.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/499c43d1cbc4/pcbi.1004857.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/5aaede9d7ba7/pcbi.1004857.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/01ef389c5ca2/pcbi.1004857.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2421/4831758/3321c48c116f/pcbi.1004857.g009.jpg

相似文献

1
Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment.整合抗菌治疗与宿主免疫以对抗耐药性感染:传统治疗与适应性治疗
PLoS Comput Biol. 2016 Apr 14;12(4):e1004857. doi: 10.1371/journal.pcbi.1004857. eCollection 2016 Apr.
2
Opportunities for the development of novel therapies based on host-microbial interactions.基于宿主-微生物相互作用开发新型疗法的机会。
Pharmacol Res. 2016 Oct;112:68-83. doi: 10.1016/j.phrs.2016.04.005. Epub 2016 Apr 20.
3
Treatment timing shifts the benefits of short and long antibiotic treatment over infection.治疗时机改变了短期和长期抗生素治疗对感染的益处。
Evol Med Public Health. 2020 Nov 23;2020(1):249-263. doi: 10.1093/emph/eoaa033. eCollection 2020.
4
Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance.开发新型基于宿主的疗法,靶向巨噬细胞和中性粒细胞中的杀菌反应,以对抗细菌抗菌耐药性。
Front Immunol. 2020 Jun 5;11:786. doi: 10.3389/fimmu.2020.00786. eCollection 2020.
5
Optimizing antimicrobial prescribing: a practical decalogue.优化抗菌药物处方:实用十诫。
Rev Esp Quimioter. 2017 Sep;30 Suppl 1:56-60.
6
Aggressive or moderate drug therapy for infectious diseases? Trade-offs between different treatment goals at the individual and population levels.积极或温和的药物治疗传染病?个体和人群层面不同治疗目标之间的权衡。
PLoS Comput Biol. 2019 Aug 12;15(8):e1007223. doi: 10.1371/journal.pcbi.1007223. eCollection 2019 Aug.
7
Host-directed therapies for bacterial and viral infections.宿主导向疗法治疗细菌和病毒感染。
Nat Rev Drug Discov. 2018 Jan;17(1):35-56. doi: 10.1038/nrd.2017.162. Epub 2017 Sep 22.
8
Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host.宿主对流感感染的细胞适应性免疫反应中交叉反应性和记忆的建模。
J Theor Biol. 2017 Jan 21;413:34-49. doi: 10.1016/j.jtbi.2016.11.008. Epub 2016 Nov 15.
9
Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections.探讨抗生素与免疫反应在治疗急性自限性感染中的协同作用。
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8331-8. doi: 10.1073/pnas.1400352111. Epub 2014 May 19.
10
Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.先天免疫和暴露间隔决定了二次流感病毒感染的动态变化,并解释了观察到的病毒层级关系。
PLoS Comput Biol. 2015 Aug 18;11(8):e1004334. doi: 10.1371/journal.pcbi.1004334. eCollection 2015 Aug.

引用本文的文献

1
Progress in brucellosis immune regulation inflammatory mechanisms and diagnostic advances.布鲁氏菌病免疫调节炎症机制及诊断进展
Eur J Med Res. 2025 Sep 1;30(1):830. doi: 10.1186/s40001-025-03068-3.
2
Modeling spatial evolution of multi-drug resistance under drug environmental gradients.建立药物环境梯度下多药耐药性的空间演变模型。
PLoS Comput Biol. 2024 May 31;20(5):e1012098. doi: 10.1371/journal.pcbi.1012098. eCollection 2024 May.
3
Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic Resistance.

本文引用的文献

1
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
2
A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.一种整合宿主免疫与抗生素动力学以研究结核病治疗的计算工具。
J Theor Biol. 2015 Feb 21;367:166-179. doi: 10.1016/j.jtbi.2014.11.021. Epub 2014 Dec 9.
3
Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics.
肺炎链球菌再感染期间触发 Toll 样受体 5 信号转导可防止抗生素耐药性的选择。
J Infect Dis. 2024 Nov 15;230(5):e1126-e1135. doi: 10.1093/infdis/jiae239.
4
Current alternative therapies for treating drug-resistant causing ophthalmia neonatorum.治疗耐药性淋病引起的新生儿眼炎的当前替代疗法。
Future Microbiol. 2024;19(7):631-647. doi: 10.2217/fmb-2023-0251. Epub 2024 Mar 21.
5
Modeling spatial evolution of multi-drug resistance under drug environmental gradients.药物环境梯度下多药耐药性的空间演变建模
bioRxiv. 2023 Nov 17:2023.11.16.567447. doi: 10.1101/2023.11.16.567447.
6
Exogenous metabolite feeding on altering antibiotic susceptibility in Gram-negative bacteria through metabolic modulation: a review.外源性代谢物通过代谢调节改变革兰氏阴性菌对抗生素敏感性的研究进展:综述。
Metabolomics. 2022 Jul 4;18(7):47. doi: 10.1007/s11306-022-01903-w.
7
A Review: Antimicrobial Therapy for Human Pythiosis.综述:人类腐皮病的抗菌治疗
Antibiotics (Basel). 2022 Mar 26;11(4):450. doi: 10.3390/antibiotics11040450.
8
Effects of Four Antibiotics on the Diversity of the Intestinal Microbiota.四种抗生素对肠道微生物多样性的影响。
Microbiol Spectr. 2022 Apr 27;10(2):e0190421. doi: 10.1128/spectrum.01904-21. Epub 2022 Mar 21.
9
Price equation captures the role of drug interactions and collateral effects in the evolution of multidrug resistance.价格方程捕捉了药物相互作用和副作用在多药耐药性演变中的作用。
Elife. 2021 Jul 22;10:e64851. doi: 10.7554/eLife.64851.
10
The Effect of Colistin Treatment on the Selection of Colistin-Resistant in Weaner Pigs.黏菌素治疗对断奶仔猪耐黏菌素菌株选择的影响。
Antibiotics (Basel). 2021 Apr 20;10(4):465. doi: 10.3390/antibiotics10040465.
抗菌药物使用时机影响疾病流行期间抗菌药物耐药性的进化。
Evol Med Public Health. 2014 Nov 5;2014(1):150-61. doi: 10.1093/emph/eou027.
4
The path of least resistance: aggressive or moderate treatment?阻力最小的途径:积极治疗还是适度治疗?
Proc Biol Sci. 2014 Nov 7;281(1794):20140566. doi: 10.1098/rspb.2014.0566.
5
Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.群体药物给药对埃及血吸虫保护性免疫发展的预测影响。
PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3059. doi: 10.1371/journal.pntd.0003059. eCollection 2014.
6
Case report: failure under azithromycin treatment in a case of bacteremia due to Salmonella enterica Paratyphi A.病例报告:伤寒甲型副伤寒沙门菌菌血症患者使用阿奇霉素治疗失败。
BMC Infect Dis. 2014 Jul 20;14:404. doi: 10.1186/1471-2334-14-404.
7
Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections.探讨抗生素与免疫反应在治疗急性自限性感染中的协同作用。
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8331-8. doi: 10.1073/pnas.1400352111. Epub 2014 May 19.
8
Targeting virulence: can we make evolution-proof drugs?靶向毒力:我们能否制造出防进化的药物?
Nat Rev Microbiol. 2014 Apr;12(4):300-8. doi: 10.1038/nrmicro3232.
9
Resource competition may lead to effective treatment of antibiotic resistant infections.资源竞争可能有助于有效治疗抗生素耐药感染。
PLoS One. 2013 Dec 13;8(12):e80775. doi: 10.1371/journal.pone.0080775. eCollection 2013.
10
Aggressive chemotherapy and the selection of drug resistant pathogens.强化化疗与耐药病原体的选择。
PLoS Pathog. 2013 Sep;9(9):e1003578. doi: 10.1371/journal.ppat.1003578. Epub 2013 Sep 12.